Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Original Research

The pattern of histopathological presentation in younger (< 40 years) and elder age(>40 years) breast cancer patients: a retrospective study from a tertiary cancer center

Subrat Kumar Samantara, Kusumbati Besra, Padmalaya Devi, Sagarika Samantaray, Sashibhusan Dash.

Introduction: Breast cancer among young women is found to have a more aggressive behaviour and trends to be diagnosed at an advanced stage but the reason still remains unclear. This study aims to evaluate the clinicohistopathological characteristics of breast carcinoma ≤40 years in comparison to that over >40 years ago. Methods: Hospital-based retrospective study was done over a period of three years from January 2017 to December 2019 at Acharya Harihar Post Graduate Institute of Cancer, Cuttack. Patients who were diagnosed with breast carcinoma and subsequent underwent breast surgery were included. The cases were divided into a “young” ≤40 years group and an “older” >40 years group. Clinicohistopathological parameters such as age, sex, tumour site, tumour size, tumour type, tumour grade, lymphovascular invasion (LVSI), perineural invasion (PNI), presence of tumour necrosis, T stage, nodal positivity, hormonal expression were retrieved from the hospital record. Results: A total of 589 patients were included during this study period, out of which 166 (28.18%) were ≤40 years and 423 (71.81%) were >40 years ago. Compared with the elderly patients,89 (53.61%) breast cancer in young patients were poorly differentiated(P=0.0000606; significant). One hundred and sixteen patients (69.87%) presented with T3/T4 as compared to 240 (56.73%)patients in the above >40 years age group. (P= 0.0033; significant). The double-positive expression of the estrogen receptor (ER) and PR (i.e., ER+/PR+) in the two groups were 63 (37.95%) and 225 (53.19%) respectively. However, 46 (27.71)% of patients were triple-negative in the ≤40 years age group versus 84 (18.85%) in the >40 years age group. Conclusion: Younger age patients were associated with high tumour grade, stage, PNI, LVSI, tumour necrosis, the negative status of progesterone (PR) and estrogen receptor (ER), and triple-negative subtype of the tumour. 

Key words: Breast cancer, young patients, histopathological characteristics, prognostic factors

Similar Articles

Disparities in Genetic Testing for Heritable Solid-Tumor Malignancies.
Dillon J, Ademuyiwa FO, Barrett M, Moss HA, Wignall E, Menendez C, Hughes KS, Plichta JK
Surgical oncology clinics of North America. 2022; 31(1): 109-126

Financial Toxicity and Shared Decision Making in Oncology.
Greenup RA
Surgical oncology clinics of North America. 2022; 31(1): 1-7

Epsin 3 potentiates the NF‑κB signaling pathway to regulate apoptosis in breast cancer.
Wu Q, Li Q, Zhu W, Zhang X, Li H
Molecular medicine reports. 2022; 25(1):

Organelle-inspired supramolecular nanomedicine to precisely abolish liver tumor growth and metastasis.
Zhan J, Wang Y, Ma S, Qin Q, Wang L, Cai Y, Yang Z
Bioactive materials. 2022; 9(): 120-133

Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer.
Teunissen FR, Wortel RC, Wessels FJ, Claes A, van de Pol SMG, Rasing MJA, Meijer RP, van Melick HHE, de Boer JCJ, Verkooijen HM, van der Voort van Zyp JRN
Clinical and translational radiation oncology. 2022; 32(): 29-34

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.

ScopeMed Web Sites